$192.28
14.638.24%
Last update: Nov 9, 4:39 AM
Revolution Medicines Inc
RVMDNASDAQ
The average analyst price target for Revolution Medicines is $211.17, 8.6% above the current price. Of 26 analysts, 25 rate it Buy and 1 Hold. Targets range from $67 to $350. The latest change came on Nov 6, 2026, when HC Wainwright & Co. raised its price target on Revolution Medicines from $280 to $350 and kept a Buy rating.
Price Target Range — 7 Quarters
Analyst Consensus — 26 Analysts
Rating Trend — Last 9 Months
